Sitemap
- About Us
- Overview
- Board of Directors
- Management Team
- Partners
- Strategy
- History
- Careers
- FAQ
- When was GW established?
- What is GW Pharmaceuticals?
- How many staff does GW have?
- Where is GW located?
- What are the aims of GW Pharmaceuticals?
- Does GW carry out research under special licences?
- Which countries does GW carry out its research in?
- How do cannabinoids work?
- Is GW researching other cannabinoids besides THC?
- What trials has GW conducted?
- What research is required to obtain regulatory approvals for GW’s products?
- How are these cannabinoid medications administered to patients?
- Do patients get high when using GW’s cannabinoid medications?
- What is GW's position on crude herbal cannabis?
- Why not just let patients smoke cannabis?
- Why has GW devoted so much time and effort to make a cannabinoid pharmaceutical product?
- How does GW produce its cannabinoid medications?
- What are cannabinoids?
- What does GW do with the herbal material?
- Where does GW grow cannabis?
- Why does GW cultivate its own cannabis plants?
- What is multiple sclerosis (MS)?
- What is spasticity?
- What is Sativex®?
- How does Sativex® work?
- What side effects does Sativex® have?
- Will patients experience a ‘high’ with Sativex®?
- Who markets Sativex?
- Does approval of Sativex by a national medicines regulatory authority mean that herbal cannabis will also be legal in that country?
- Where is Sativex® available?
- Who are GW's financial advisers and brokers?
- Which financial PR firm does GW Pharmaceuticals use?
- How do I obtain a copy of the company's annual report?
- What is the stock exchange symbol for GW Pharmaceuticals?
- When is the company's financial year end?
- Which stock exchange is GW Pharmaceuticals listed on?
- Contact Us
- Sativex
- Partners
- UK Information
- Patient Information
- Prescriber Information
- Sativex R&D
- Mechanism of Action
- What is multiple sclerosis (MS)?
- What is spasticity?
- What is Sativex®?
- How does Sativex work?
- Will patients experience a ‘high’ with Sativex®
- Who markets Sativex?
- Does approval of Sativex by a national medicines regulatory authority mean that herbal cannabis will also be legal in that country?
- Where is Sativex® available?
- R&D
- Cannabinoid Science
- Therapeutic Areas
- Product Pipeline
- Partnering
- R&D Collaborations
- Cultivation
- GW Metabolic Research Laboratory
- Cannabinoid Research Institute
- Research Papers
- What trials has GW conducted?
- What research is required to obtain regulatory approvals for GW’s products
- Is GW researching other cannabinoids besides THC?
- Do patients get high when using GW’s cannabinoid medications?
- How are these cannabinoid medications administered to patients?
- What is GW's position on crude herbal cannabis?
- Why not just let patients smoke cannabis?
- Why has GW devoted so much time and effort to make a cannabinoid pharmaceutical product?
- What does GW do with the herbal material?
- Where does GW grow cannabis?
- Why does GW cultivate its own cannabis plants?
- How does GW produce its cannabinoid medications?
- How do cannabinoids work?
- What are cannabinoids?
- Investors
- Email Alerts
- Financial Reports
- Share Price & Chart
- Calendar and Events
- Shareholder Services
- Shareholder FAQ
- Who are GW's financial advisers and brokers?
- Which financial PR firm does GW Pharmaceuticals use?
- How do I obtain a copy of the company's annual report?
- What is the stock exchange symbol for GW Pharmaceuticals?
- When is the company's financial year end?
- Which stock exchange is GW Pharmaceuticals listed on?
- Analyst Coverage
- AIM Rule 26
- Securities in Issue
- Advisers
- Corporate Governance
- IR Contacts